Cargando…
Blockade of SARS-CoV-2 infection by recombinant soluble ACE2
Autores principales: | Alhenc-Gelas, Francois, Drueke, Tilman B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc. on behalf of the International Society of Nephrology.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194930/ https://www.ncbi.nlm.nih.gov/pubmed/32354636 http://dx.doi.org/10.1016/j.kint.2020.04.009 |
Ejemplares similares
-
From confusion to clarity: RAS blockade in patients hospitalized with COVID-19
por: Geherty, Raymond A., et al.
Publicado: (2021) -
The SARS-CoV-2 main protease as drug target
por: Ullrich, Sven, et al.
Publicado: (2020) -
How does diabetes cause susceptibility to COVID-19 in the kidney: new clues provided by organoids
por: Xia, Yun, et al.
Publicado: (2022) -
Repurposing UDCA, an FXR Inhibitor, to Prevent SARS-Cov-2 Infection
por: Prayitno, Khairunnadiya, et al.
Publicado: (2023) -
Predicting SARS-CoV-2 infection among hemodialysis patients using multimodal data
por: Duan, Juntao, et al.
Publicado: (2023)